D-0909-2023 Class II Terminated
FDA drug recall D-0909-2023 was initiated by L. Perrigo Company on Feb 9, 2023 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Sep 11, 2023). Affected quantity: 32,904 cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- Jul 19, 2023
- Initiation Date
- Feb 9, 2023
- Termination Date
- Sep 11, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 32,904 cartons
Product Description
allergyrelief, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a)30-count cartons (NDC 56062-847-39); and b) 45-count cartons (NDC 56062-847-95), Distributed by: Publix Super Markets, Inc., 3300 Publix Corporate Parkway, Lakeland, FL 33811.
Reason for Recall
Failed Impurities/Degradation Specifications
Distribution Pattern
Nationwide within the USA
Code Information
Lot #: a) 2CR0652, 2DR0464, 2DR0465,Exp. Date 12/23; 2ER0285, Exp. Date 01/24. b) 2DR0466, Exp. Date 12/23; 2ER0412, Exp. Date 01/24; 2GR0330, Exp. Date 04/24
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0909-2023
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026